Colorado State University engineers are now poised to help fulfill projected demand for close to 50,000 medical masks per day for nurses, doctors and other health care providers. In support of their efforts, they’ve received a $25,000 grant from the Colorado Clinical and Translational Sciences Institute under the COVID-19-Related Research Pilot program,, which just announced four statewide winners out of over 50 applicants.









The CSU team led by David ...

Brand new Virustatic Shield gives anti-viral protection for you and your family. The easy-to-wear snood helps prevent infection.

The coating is designed to be applied to single-layer materials for pandemic situations. The coating transforms the base material into an anti-viral, multi-functional protective snood. So light and breathable you won’t believe its virus stopping power. Proven to trap and kill airborne enveloped influenza viruses.

Click here for reference

Across the world, countries are embarking on enormous experiments in ending coronavirus lockdown measures - and others are looking on nervously, asking themselves what's the best way back to normality.

There's no international consensus over how best to do it - but we've looked at the key trends that are emerging, and some of the innovative thinking leading the way.

Click here for reference

A young couple in Columbus, Ohio, came up with a unique way to clean and reuse critically needed N95 masks. This breakthrough system rolling out across the country provides some relief for health care workers struggling with a lack of personal protective equipment.Click here for reference

Considering that any patient who is admitted to the intensive care unit (ICU) might be infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), we present a video of tracheal intubation performed in an operating room, using two different devices for laryngoscopy (video). As recommended by airway management societies worldwide, we used a rapid sequence induction, and face mask ventilation was avoided. In part 1 of the video, the use of standard Macintosh laryngoscope for tra...

Coronavirus disease 2019 (COVID-19) was announced a pandemic by WHO on March 11, 2020. As of May 3, 2020, Italy is one of the countries hit hardest by the COVID-19 pandemic, with 28 884 confirmed deaths. In addition to pulmonary insufficiency, COVID-19 is associated with other life-threatening complications such as sepsis, heart failure, and pulmonary embolism. Here we describe patients with COVID-19 who presented with acute limb ischaemia but did not have atherosclerosis, atrial fibrillation...

The COVID-19 epidemic is believed to have started in late January 2020 in France. We report here a case of a patient hospitalized in December 2019 in our intensive care, of our hospital in the north of Paris, for hemoptysis with no etiological diagnosis and for which RT-PCR was performed retrospectively on the stored respiratory sample which confirmed the diagnosis of COVID-19 infection. Based on this result, it appears that the COVID-19 epidemic started much earlier.


Click her...

Dr. X could not help her sick family members, but her eagerness to do something grew. She knew that in China, plasma from recovered people, which contains antibodies to the virus, was showing promise as a treatment. Her doctor told her about a project, a collaboration between Vanderbilt University and AstraZeneca, to develop something safer and more powerful. It aims to go beyond the mishmash of antibodies in convalescent plasma and pull out the equivalent of a guided missile: an antibody...

The company has developed the test in record time in a global coordinated effort of its facilities in San Diego, Barcelona and Bilbao, and has recently received the authorization of the Spanish Medicines and Medical Devices Agency (AEMPS) for its use in blood, plasma and respiratory samples. It has a sensitivity equal or even superior to that of other molecular tests currently available, such as those based on PCR.


Thanks to this high sensitivity, the molecular test will also permi...

Reverse genetics has been an indispensable tool revolutionising insights into viral pathogenesis and vaccine development. Large RNA virus genomes, such as from Coronaviruses, are cumbersome to clone and manipulate in E. coli due to size and occasional instability1–3. Therefore, an alternative rapid and robust reverse genetics platform for RNA viruses would benefit the research community. Here we show the full functionality of a yeast-based synthetic genomics platform to genetically recons...

Now, as the death toll from the COVID-19 pandemic surges, researchers are scrambling to uncover as much as possible about the biology of the latest coronavirus, named SARS-CoV-2. A profile of the killer is already emerging. Scientists are learning that the virus has evolved an array of adaptations that make it much more lethal than the other coronaviruses humanity has met so far. Unlike close relatives, SARS-CoV-2 can readily attack human cells at multiple points, with the lungs and the throa...